Drug Type Small molecule drug |
Synonyms |
Target |
Action inhibitors |
Mechanism KIF18A inhibitors(kinesin family member 18A inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Advanced Colorectal Adenocarcinoma | Preclinical | China | 02 Apr 2024 | |
Ovarian Cancer | Preclinical | China | 22 Mar 2024 |